HK1005248A1 - Gene expression in mammalian cells - Google Patents
Gene expression in mammalian cellsInfo
- Publication number
- HK1005248A1 HK1005248A1 HK98104482A HK98104482A HK1005248A1 HK 1005248 A1 HK1005248 A1 HK 1005248A1 HK 98104482 A HK98104482 A HK 98104482A HK 98104482 A HK98104482 A HK 98104482A HK 1005248 A1 HK1005248 A1 HK 1005248A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- gene expression
- mammalian cells
- mammalian
- cells
- gene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/108—Plasmid DNA episomal vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/60—Vector systems having a special element relevant for transcription from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9506051.3A GB9506051D0 (en) | 1995-03-24 | 1995-03-24 | Gene expression |
PCT/CA1996/000174 WO1996030531A1 (en) | 1995-03-24 | 1996-03-22 | Gene expression in mammalian cells |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1005248A1 true HK1005248A1 (en) | 1998-12-31 |
Family
ID=10771834
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK98104482A HK1005248A1 (en) | 1995-03-24 | 1998-05-25 | Gene expression in mammalian cells |
Country Status (16)
Country | Link |
---|---|
US (1) | US6207146B1 (pt) |
EP (1) | EP0815251A1 (pt) |
JP (1) | JPH11502705A (pt) |
KR (1) | KR19980703275A (pt) |
CN (1) | CN1185180A (pt) |
AP (1) | AP730A (pt) |
AU (1) | AU722341B2 (pt) |
BR (1) | BR9607831A (pt) |
CA (1) | CA2216174A1 (pt) |
GB (2) | GB9506051D0 (pt) |
HK (1) | HK1005248A1 (pt) |
HU (1) | HUP9800520A3 (pt) |
IL (1) | IL117594A (pt) |
NO (1) | NO974367L (pt) |
NZ (1) | NZ303133A (pt) |
WO (1) | WO1996030531A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002310922A1 (en) * | 2001-05-04 | 2002-11-18 | Institute Of Molecular And Cell Biology | Interferons in the treatment of ischemia |
FR2843973B1 (fr) * | 2002-08-30 | 2006-07-07 | Agronomique Inst Nat Rech | Cassettes d'expression procaryotes regulees par le zinc |
GB0524782D0 (en) * | 2005-12-05 | 2006-01-11 | Chiron Srl | Analysis of samples |
CN100432230C (zh) * | 2006-05-11 | 2008-11-12 | 南京大学 | 一种金属硫蛋白融合表达方法及其应用 |
EP2205752B1 (en) * | 2007-10-25 | 2016-08-10 | Sangamo BioSciences, Inc. | Methods and compositions for targeted integration |
LT3768846T (lt) * | 2018-03-21 | 2023-08-10 | Aldevron, L.L.C. | Virusiniai ir nevirusiniai nanoplazmidiniai vektoriai su patobulinta gamyba |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5514567A (en) | 1979-01-30 | 1996-05-07 | Juridical Foundation, Japanese Foundation For Cancer Research | DNA and recombinant plasmid |
AU538665B2 (en) | 1979-10-30 | 1984-08-23 | Juridical Foundation, Japanese Foundation For Cancer Research | Human interferon dna |
US4966843A (en) | 1982-11-01 | 1990-10-30 | Cetus Corporation | Expression of interferon genes in Chinese hamster ovary cells |
WO1986004920A1 (en) * | 1985-02-13 | 1986-08-28 | Biotechnology Research Partners, Limited | Human metallothionein-ii promoter in mammalian expression system |
GB2177914B (en) | 1985-06-04 | 1989-10-25 | Chugai Pharmaceutical Co Ltd | A pharmaceutical composition containing human erythropoietin and a surface active agent for nasal administration for the treatment of anemia |
US4954437A (en) * | 1986-09-15 | 1990-09-04 | Integrated Genetics, Inc. | Cell encoding recombinant human erythropoietin |
CA1294215C (en) * | 1986-10-27 | 1992-01-14 | Ze'ev Shaked | Pharmaceutical compositions of recombinant beta-interferon and formulation processes |
DE3712564A1 (de) | 1987-04-14 | 1988-11-24 | Bioferon Biochem Substanz | Verfahren zur konstruktion einer animalen zellinie fuer die herstellung von humanem interferon-beta |
DD287531A5 (de) * | 1988-06-16 | 1991-02-28 | Akademie Der Wissenschaften,De | Verfahren zur herstellung von humanem wachstumshormon (sth) in tierischen zellen |
DE4128319A1 (de) * | 1991-08-27 | 1993-03-04 | Bioferon Biochem Substanz | Neues rekombinantes human-ifn-beta, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen |
EP0551535A1 (en) * | 1992-01-13 | 1993-07-21 | SCLAVO S.p.A. | Process for the purification of recombinant human beta interferon, beta interferon thus purified, and pharmaceutical compositions which contain them |
-
1995
- 1995-03-24 GB GBGB9506051.3A patent/GB9506051D0/en active Pending
-
1996
- 1996-03-21 IL IL11759496A patent/IL117594A/en not_active IP Right Cessation
- 1996-03-22 US US08/913,778 patent/US6207146B1/en not_active Expired - Fee Related
- 1996-03-22 HU HU9800520A patent/HUP9800520A3/hu unknown
- 1996-03-22 CA CA002216174A patent/CA2216174A1/en not_active Abandoned
- 1996-03-22 AU AU49358/96A patent/AU722341B2/en not_active Ceased
- 1996-03-22 CN CN96194053A patent/CN1185180A/zh active Pending
- 1996-03-22 GB GB9720467A patent/GB2314332B/en not_active Expired - Fee Related
- 1996-03-22 NZ NZ303133A patent/NZ303133A/xx unknown
- 1996-03-22 EP EP96905646A patent/EP0815251A1/en not_active Withdrawn
- 1996-03-22 BR BR9607831-6A patent/BR9607831A/pt not_active Application Discontinuation
- 1996-03-22 AP APAP/P/1997/001091A patent/AP730A/en active
- 1996-03-22 KR KR1019970706679A patent/KR19980703275A/ko not_active Application Discontinuation
- 1996-03-22 WO PCT/CA1996/000174 patent/WO1996030531A1/en not_active Application Discontinuation
- 1996-03-22 JP JP8528730A patent/JPH11502705A/ja not_active Withdrawn
-
1997
- 1997-09-22 NO NO974367A patent/NO974367L/no not_active Application Discontinuation
-
1998
- 1998-05-25 HK HK98104482A patent/HK1005248A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU4935896A (en) | 1996-10-16 |
US6207146B1 (en) | 2001-03-27 |
IL117594A0 (en) | 1996-07-23 |
EP0815251A1 (en) | 1998-01-07 |
GB2314332B (en) | 1999-06-30 |
NO974367D0 (no) | 1997-09-22 |
KR19980703275A (ko) | 1998-10-15 |
MX9707244A (es) | 1998-08-30 |
CA2216174A1 (en) | 1996-10-03 |
NZ303133A (en) | 1999-11-29 |
IL117594A (en) | 2002-11-10 |
BR9607831A (pt) | 1999-11-30 |
CN1185180A (zh) | 1998-06-17 |
AP9701091A0 (en) | 1997-10-31 |
JPH11502705A (ja) | 1999-03-09 |
GB2314332A (en) | 1997-12-24 |
HUP9800520A3 (en) | 1999-09-28 |
GB9506051D0 (en) | 1995-05-10 |
AU722341B2 (en) | 2000-07-27 |
GB9720467D0 (en) | 1997-11-26 |
HUP9800520A2 (hu) | 1998-06-29 |
WO1996030531A1 (en) | 1996-10-03 |
AP730A (en) | 1999-02-04 |
NO974367L (no) | 1997-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA964776B (en) | Mammalian cell culture process. | |
GB2302757B (en) | Electrochemical cell | |
GB9504446D0 (en) | Improvements in or relating to gene expression | |
IL125126A (en) | Electroconversion cell | |
AU7612196A (en) | Functional human hematopoietic cells | |
DE69617583D1 (de) | In vitrozellkultur-System | |
AU6855796A (en) | In vivo electroporation of cells | |
GB2314332B (en) | Gene expression in mammalian cells | |
GB9516556D0 (en) | Cell culture laminate | |
GB9714936D0 (en) | Cell culture products | |
GB9605453D0 (en) | Cultured cells | |
IL113641A (en) | Electrochemical cell | |
GB2298955B (en) | Fuel cells | |
AU8105798A (en) | Mammalian cell transduction for use in gene therapy | |
AU9003298A (en) | Mammalian genes participating in circadian period | |
GB9709407D0 (en) | Cell culture methods | |
GB9715422D0 (en) | Cell culture products | |
GB9725209D0 (en) | Cell culture products | |
GB9321937D0 (en) | Cultured cells | |
GB9509810D0 (en) | Cell specific expression | |
GB9508469D0 (en) | Cell specific expression | |
HUP9902752A3 (en) | Cell culture media for mammalian cells | |
GB9618249D0 (en) | Cell culture | |
GB9513428D0 (en) | Culturing of cells | |
GB9526578D0 (en) | Electrochemical cell |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20040322 |
|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |